It’s not an easy environment for health-care investors, with the sector front and center of political debates, but a bigger concern might be stemming from a key regulator: the U.S. Food and Drug Administration.
Acquisition adds talent and proprietary therapeutic platform to accelerate next-generation cancer immunotherapy
Xyphos shareholders to receive up to $665 million in structured, milestone-based acquisition
Discovery of Cellular Mechanisms Could Open Door to More Effective Anti-Aging Therapies
A new study shows how tiny robotic vessels powered by acoustic waves and an on-board bubble motor can be maneuvered through cellular landscapes using magnets.